COVID-19: Vaccines and Therapeutics

Dec 2, 2020
An independent advisory group for the Centers for Disease Control and Prevention recommended health care personnel and long-term care facility residents receive vaccinations against COVID-19 in the program’s initial phase.
Dec 1, 2020
In an open letter to the American public, the AHA, along with the American Medical Association and American Nurses Association, affirmed their support for vaccines as a critical means for protecting individuals, communities and loved ones from COVID-19.
Dec 1, 2020
In an open letter to the American public, the AHA, along with the American Medical Association and American Nurses Association, today affirmed their support for vaccines as a critical means for protecting individuals, communities and loved ones from COVID-19, the worst global health crisis in…
Dec 1, 2020
As COVID-19 vaccine development continues to progress, leading U.S. medical, nursing and health organizations today affirmed their commitment to ensuring COVID-19 vaccines are evaluated and ultimately authorized through a rigorous scientific and regulatory process.
Nov 30, 2020
Following analysis of additional primary efficacy data for its mRNA-1273 COVID-19 vaccine candidate, Moderna Inc. said it will apply for emergency use authorization from the Food and Drug Administration.
Nov 24, 2020
The Centers for Medicare & Medicaid Services released updated guidance for states and territories on Medicaid, Children’s Health Insurance Program and Basic Health Program coverage and reimbursement for COVID-19 vaccinations.
Nov 24, 2020
The Centers for Disease Control and Prevention released recommendations for the ethical allocation of COVID-19 vaccines, once available to the public.
Nov 23, 2020
The Food and Drug Administration authorized administering the monoclonal antibodies casirivimab and imdevimab together to certain COVID-19 outpatients at risk for severe disease.
Nov 23, 2020
Drug maker AstraZeneca said it will seek an emergency use authorization for its AZD1222 vaccine candidate for SARS-CoV-2 following positive high-level results from an interim analysis of ongoing clinical trials.
Nov 23, 2020
The Food and Drug Administration authorized the emergency use of baricitinib in combination with remdesivir to treat suspected or laboratory confirmed COVID-19 in certain hospitalized patients requiring supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation.